Literature DB >> 30098721

Gastric Carcinoids.

Simona Grozinsky-Glasberg1, Krystallenia I Alexandraki2, Anna Angelousi2, Eleftherios Chatzellis2, Stavros Sougioultzis3, Gregory Kaltsas4.   

Abstract

Gastric carcinoids, formally named gastric neuroendocrine neoplasms (NENs), are derived from enterochromaffin-like cells of the stomach and are increasingly diagnosed. A majority are designated as type I (related to autoimmune gastritis) and type II (related to gastrinoma) neoplasms that develop secondary to gastrin hypersecretion. Types I and II gastric carcinoids are mostly small-sized (1-2 cm), multiple, low-malignancy potential lesions mainly confined to the gastric mucosa/submucosa. These lesions have an indolent course and low metastatic potential. In contrast, type III gastric carcinoids are single, larger-sized (>2 cm), non-gastrin-related lesions that infiltrate the muscular layers associated with local and distant metastases.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrophic gastritis; Carcinoids; Endoscopic ultrasound; Gastrin; Neuroendocrine

Mesh:

Year:  2018        PMID: 30098721     DOI: 10.1016/j.ecl.2018.04.013

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  14 in total

Review 1.  How to Select Patients Affected by Neuroendocrine Neoplasms for Surgery.

Authors:  Francesca Fermi; Valentina Andreasi; Francesca Muffatti; Stefano Crippa; Domenico Tamburrino; Stefano Partelli; Massimo Falconi
Journal:  Curr Oncol Rep       Date:  2022-01-25       Impact factor: 5.075

Review 2.  Gastric neuroendocrine neoplasms: a primer for radiologists.

Authors:  Molly E Roseland; Isaac R Francis; Kimberly L Shampain; Erica B Stein; Ashish P Wasnik; John D Millet
Journal:  Abdom Radiol (NY)       Date:  2022-04-12

3.  Type I Gastric Neuroendocrine Tumor Presenting as Acute Upper Gastrointestinal Bleed.

Authors:  Anusha Bapatla; Ameena Syed; Abu Fazal Shaik Mohammed; Cortney V Jones; Rana Ismail
Journal:  Cureus       Date:  2021-05-31

4.  Black swans - neuroendocrine tumors of rare locations.

Authors:  Christian A Koch; S Petersenn
Journal:  Rev Endocr Metab Disord       Date:  2018-06       Impact factor: 6.514

5.  Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis.

Authors:  Roberta Elisa Rossi; Pietro Invernizzi; Vincenzo Mazzaferro; Sara Massironi
Journal:  United European Gastroenterol J       Date:  2019-11-22       Impact factor: 4.623

6.  NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis.

Authors:  Anna Malczewska; Kjell Oberg; Beata Kos-Kudla
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

7.  The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK.

Authors:  A Malczewska; A Procner; A Walter; K Kusnierz; W Zajecki; H Aslanian; B Kos-Kudla
Journal:  BMC Gastroenterol       Date:  2020-07-23       Impact factor: 3.067

8.  Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.

Authors:  Apostolos V Tsolakis; Athanasia Ragkousi; Miroslav Vujasinovic; Gregory Kaltsas; Kosmas Daskalakis
Journal:  World J Gastroenterol       Date:  2019-09-21       Impact factor: 5.742

Review 9.  Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.

Authors:  Lingaku Lee; Irene Ramos-Alvarez; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Mol Sci       Date:  2019-10-16       Impact factor: 5.923

Review 10.  A narrative review of multiple endocrine neoplasia syndromes: genetics, clinical features, imaging findings, and diagnosis.

Authors:  Xuefang Hu; Jian Guan; Yangdi Wang; Siya Shi; Chenyu Song; Zi-Ping Li; Shi-Ting Feng; Jie Chen; Yanji Luo
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.